Tango Therapeutics (TNGX) Prepaid Assets (2020 - 2026)
Tango Therapeutics' (TNGX) quarterly Prepaid Assets came in at $12.5 million in Q1 2026, up 60.56% year-on-year from $7.8 million in Q1 2025, and up 22.55% quarter-over-quarter from $10.2 million in Q4 2025.
Tango Therapeutics (TNGX) Prepaid Assets (2020 - 2026) Analysis & Trends
Tango Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $12.5 million for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 60.56% year-over-year to $12.5 million in Q1 2026; TTM through Mar 2026 was $12.5 million, a 60.56% increase from a year earlier, with the FY2025 full-year figure at $10.2 million, up 20.94% from the prior year.
- Prepaid Assets improved to $12.5 million in Q1 2026 per TNGX's latest filing, from $10.2 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $17.2 million in Q2 2022 and bottomed at $5.8 million in Q3 2022.
- The 5-year median for Prepaid Assets is $8.8 million (2023), against an average of $9.2 million.
- Across the five-year window, Prepaid Assets surged 11238.91% in 2022 and sank 47.35% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $6.6 million in 2022, then jumped by 33.86% to $8.8 million in 2023, then declined by 4.22% to $8.4 million in 2024, then grew by 20.94% to $10.2 million in 2025, then rose by 22.55% to $12.5 million in 2026.
- Per Business Quant, the three latest TNGX Prepaid Assets figures stand at $12.5 million (Q1 2026), $10.2 million (Q4 2025), and $10.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tango Therapeutics | 3.94 Bn | 3.78 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.49 Mn |
| Dec 31, 2025 | 10.19 Mn |
| Sep 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 8.89 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Dec 31, 2024 | 8.43 Mn |
| Sep 30, 2024 | 7.54 Mn |
| Jun 30, 2024 | 6.30 Mn |
| Mar 31, 2024 | 8.44 Mn |
| Dec 31, 2023 | 8.80 Mn |
| Sep 30, 2023 | 10.16 Mn |
| Jun 30, 2023 | 9.04 Mn |
| Mar 31, 2023 | 9.36 Mn |
| Dec 31, 2022 | 6.57 Mn |
| Sep 30, 2022 | 5.81 Mn |
| Jun 30, 2022 | 17.16 Mn |
| Mar 31, 2022 | 8.20 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Sep 30, 2021 | 4.53 Mn |
| Jun 30, 2021 | 151,355.00 |